Be vigorous and resolute, and be steady and farsighted! On March 24, 2022, it was comprehensively, rigorously and meticulously audited by experts. Dongfang Baitai successfully passed the ISO three system certification. This is a sign that the Oriental Baitai brand has reached international standards. It is also the embodiment of the company's quality, environment, occupational health and safety management and further strengthening and improvement.

2022 is the year of quality, innovation and green of biopharmaceutical industry. Dongfang Baitai is committed to the development of innovative antibody drugs with the attitude of an enterpriser who strives for the day and the nature of a striver who does not seek refuge.

Based on the principle of "leaders attach importance to and all staff participate in", the company has operated the system for six months and has been comprehensively, rigorously and meticulously audited by experts. Dongfang Baitai meets the requirements of ISO three system certification standards, and officially issued ISO9001 quality management system certificate, ISO45001 occupational health and safety management system certificate and ISO14001 environmental management system certificate to Dongfang Baitai on March 24, 2022.

ISO three system certification is a management system recognized by China and internationally recognized. The successful passing of the three system certification standards marks that Dongfang Baitai has established a quality management system covering the whole life cycle of products with "clear responsibilities, standardized procedures, pragmatic efficiency and comprehensive control". It also marks the further systematization, standardization and normalization of the company's scientific management.

For a long time, Dongfang Baitai adheres to the development concept of "medicine is benevolent, medicine is conscience". The company focuses on the pharmaceutical industry and key areas, lays out product pipelines with a global perspective, practices its original mission, and bears in mind its responsibilities. We always take "patients as the center and devote ourselves to creating a healthy life for human beings", so as to provide continuous impetus for promoting the rapid development of the biopharmaceutical industry.

In the future, the company will take this opportunity to dig inward and extend outward, further promote the "three systems" management and operation, and make the quality, environment, occupational health and safety management more standardized and professional. We will continue to improve and enhance the comprehensive management level to provide strong support for the company to move towards higher goals.